Adicet Bio, Inc.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 131 DARTMOUTH STREET, BOSTON, MA, 02116
Mailing Address 131 DARTMOUTH STREET, BOSTON, MA, 02116
Phone 617-482-2333
Fiscal Year End 1226
EIN 813305277
Financial Overview
FY2024
$33.61M
Total Liabilities
$186.61M
Stockholders' Equity
$159.71M
Cash & Equivalents
$-1.33
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G Passive beneficial ownership (>5%) | January 29, 2026 | View on SEC |
| 4 Insider stock transaction report | January 27, 2026 | View on SEC |
| 4 Insider stock transaction report | January 27, 2026 | View on SEC |
| 4 Insider stock transaction report | January 27, 2026 | View on SEC |
| 4 Insider stock transaction report | January 27, 2026 | View on SEC |
| 8-K Current report of material events | January 7, 2026 | View on SEC |
| 8-K Current report of material events | December 29, 2025 | View on SEC |
| 8-K Current report of material events | December 19, 2025 | View on SEC |
| DEF 14A Definitive proxy statement | November 17, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 5, 2025 | View on SEC |
Material Events
8-K Strategy Change December 29, 2025
High Impact
- Adicet Bio, Inc. announced a 1-for-16 reverse stock split to consolidate shares.
- The primary goal of the split is to increase the stock price per share to meet Nasdaq listing requirements and potentially attract institutional investors.
8-K Financial Distress December 19, 2025
High Impact
- Adicet Bio, Inc. shareholders approved a reverse stock split at a Special Meeting on December 19, 2025.
- The reverse stock split ratio will be determined by the board of directors, ranging from 1-for-5 to 1-for-30.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.